Correlation Between Health Biotchnology and Emerging Europe

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Emerging Europe at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Emerging Europe into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Emerging Europe Fund, you can compare the effects of market volatilities on Health Biotchnology and Emerging Europe and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Emerging Europe. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Emerging Europe.

Diversification Opportunities for Health Biotchnology and Emerging Europe

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Health and Emerging is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Emerging Europe Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emerging Europe and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Emerging Europe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emerging Europe has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Emerging Europe go up and down completely randomly.

Pair Corralation between Health Biotchnology and Emerging Europe

If you would invest (100.00) in Emerging Europe Fund on November 28, 2024 and sell it today you would earn a total of  100.00  from holding Emerging Europe Fund or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Health Biotchnology Portfolio  vs.  Emerging Europe Fund

 Performance 
       Timeline  
Health Biotchnology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Emerging Europe 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Emerging Europe Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Emerging Europe is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Health Biotchnology and Emerging Europe Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Biotchnology and Emerging Europe

The main advantage of trading using opposite Health Biotchnology and Emerging Europe positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Emerging Europe can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emerging Europe will offset losses from the drop in Emerging Europe's long position.
The idea behind Health Biotchnology Portfolio and Emerging Europe Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Managers
Screen money managers from public funds and ETFs managed around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets